| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 32.01M | — |
| Operating expense | — | — |
| Net income | -23.40M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, BBNX returned +11.7% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -37.5% |
| 1 year | +11.7% |
| All-time high | $31.34 (Nov 2025) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in BBNX would be worth today ›No. Beta Bionics, Inc. has not paid a dividend in the past 12 months.
Beta Bionics, Inc. stock trades on NASDAQ under the ticker symbol BBNX.
Beta Bionics, Inc. is part of the Healthcare sector.
Beta Bionics, Inc. has a market cap of 857.05M USD, based on the latest quote.
Beta Bionics, Inc. is expected to report earnings around Oct 27, 2026. That date is an estimate and has not been confirmed by the company.